| Page 11 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.
  1. Home

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Author(s): 
Sauta E, Robin M, Bersanelli M, Travaglino E, Meggendorfer M, Zhao LP, Caballero Berrocal JC, Sala C, Maggioni G, Bernardi M, Di Grazia C, Vago L, Rivoli G, Borin L, D'Amico S, Tentori CA, Ubezio M, Campagna A, Russo A, Mannina D, Lanino L, Chiusolo P,
Primary Author: 
Sauta E
Journal Title: 
Journal of Clinical Oncology
Original Publication Date: 
May 2023

Purpose: 

Bone Marrow Disease(s): 

Epidemiology and Pathogenesis of Myelodysplastic Syndrome

Author(s): 
Rotter LK, Shimony S, Ling K, Chen E, Shallis RM, Zeidan AM, Stahl M
Primary Author: 
Rotter LK
Journal Title: 
The Cancer Journal
Original Publication Date: 
May 2023

Myelodysplastic syndrome (MDS) is a clonal disorder characterized by ineffective hematopoiesis and variable cytopenias with a considerable risk of progression to

Bone Marrow Disease(s): 

Genomics of myelodysplastic/myeloproliferative neoplasm

Author(s): 
Patwardhan PP, Aarabi M, Aggarwal N
Primary Author: 
Patwardhan PP
Journal Title: 
Seminars in Diagnostic Pathology
Original Publication Date: 
May 2023

Myelodysplastic/ Myeloproliferative neoplasms (MDS/MPN) demonstrate overlapping pathologic and molecular features of myelodysplastic (MDS) and myeloproliferative (MPN) neoplasms. Diagnosis is difficult based on morphology alone, requiring exclusion of various non-neoplastic causes for CBC abnormalities and morphologic findings and other myeloid neoplasms.

Bone Marrow Disease(s): 

The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria

Author(s): 
Lazana I, Apap Mangion S, Babiker S, Large J, Trikha R, Zuckerman M, Gandhi S, Kulasekararaj AG
Primary Author: 
Lazana I
Journal Title: 
International Journal of Molecular Sciences
Original Publication Date: 
May 2023

Bone Marrow Disease(s):